SKYSTAR BIO-PHARMACEUTICAL CO Finite-Lived Intangible Assets, Gross
SKYSTAR BIO-PHARMACEUTICAL CO had Finite-Lived Intangible Assets, Gross of $7.52 million as of 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2014-11-14
- 2014-09-30: Finite-Lived Intangible Assets, Gross $7.52M.
- 2014-06-30: Finite-Lived Intangible Assets, Gross $7.52M.
- 2014-03-31: Finite-Lived Intangible Assets, Gross $7.51M.
- 2013-12-31: Finite-Lived Intangible Assets, Gross $7.57M.
| Period end | Finite-Lived Intangible Assets, Gross |
|---|---|
| 2014-09-30 | $7.52M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $7.52M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $7.51M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $7.57M 10-Q · filed 2014-11-14 |
| 2013-09-30 | $7.54M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $7.49M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $7.38M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $7.34M 10-K · filed 2014-03-31 |
| 2012-09-30 | $7.32M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $7.33M 10-Q/A · filed 2012-09-13 |
| 2011-12-31 | $7.28M 10-K · filed 2013-04-01 |